| ［1］ Shao L, Cui Y, Li H, et al. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines［J］. Clin Cancer Res, 2007, 13: 57565762.
［2］ Wang Y, Li J, Cui Y, et al. CMTM3, located at the critical tumor suppressor locus 16q22. 1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis［J］. Cancer Res, 2009, 69(12): 51945201.
［3］ 谭永丽, 谭双香, 胡瑞成. PRDM基因及DNA甲基化与肿瘤的关系［J］. 国际肿瘤学杂志, 2013, 40(3): 174176.
［4］ 沈建军, 张红雁. 表观遗传学与鼻咽癌［J］. 国际肿瘤学杂志, 2014, 41(5): 335337.
［5］ 卜梁, 姜冠潮, 王俊. 人类趋化素样因子超家族在非小细胞肺癌中的表达［J］. 中华实验外科杂志, 2009, 25(9): 11261127.
［6］ Wang J, Zhang G, Zhang Y, et al. CMTM1_v17 is a novel potential therapeutic target in breast cancer［J］. Oncol Rep, 2014, 32(5): 18291836.
［7］ Xie J, Yuan Y, Liu Z, et al. CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities［J］. Clin Transl Oncol, 2013, 16(4): 402409.
［8］ Su Y, Lin Y, Zhang L, et al. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer［J］. Cancer Sci, 2014, 105(1): 2634.
［9］ 查鹏, 姜冠潮, 王俊. 食管、贲门癌组织中CMTM4、8的表达及意义［J］. 山东医药，2009(6): 2122.
［10］ Plate M, Li T, Wang Y, et al. Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation［J］. Mol Cells, 2010, 29(4): 355361.
［11］ Guo X, Li T, Wang Y, et al. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNFalpha［J］. Biochem Biophys Res Commun, 2009, 387: 139142.
［12］ Shao L, Guo X, Plate M, et al. CMTM5v1 induces apoptosis in cervical carcinoma cells［J］. Biochem Biophys Res Commun, 2009, 379: 866871.
［13］ Li P, Liu K, Li L, et al. Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer［J］. Int J Gynecol Cancer, 2011, 21(7): 12481255.
［14］ Zhang H, Nan X, Li X, et al. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma［J］. Biochem Biophys Res Commun, 2014, 447(2): 304310.
［15］ Niu J, Li H, Yao Z, et al. Aberrant expression of CKLFlike MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia［J］. Leuk Res, 2011, 35(6): 771776.
［16］ Li H, Li J, Su Y, et al. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth［J］. Oncogene, 2014, 33(24): 31093118.
［17］ Miyazaki A, Yogosawa S, Murakami A, et al. Identification of CMTM7 as a transmembrane linker of BLNK and the BCell receptor［J］. PLoS One, 2012, 7(2): e31829.
［18］ Nakayama J, Yamamoto M, Hayashi K, et al. BLNK suppresses preBcell leukemogenesis through inhibition of JAK3［J］. Blood, 2009, 113: 14831492.
［19］ Liu Q, Su Y, Jiang GC, et al. Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human nonsmall cell lung cancer［J］. Chin Med J (Engl), 2013, 126(16): 30063012.
［20］ 陈绍倩, 杜英, 黄玉敏, 等. 新型人趋化素样因子超家族8对人白血病细胞增殖和表皮生长因子受体表达的影响［J］， 中国实验血液学杂志， 2007， 15(3)： 458461.
［21］ 胡浩, 陈京文, 许克新, 等. CMTM8与Ecadherin在原发性和转移性肾透明细胞癌中的表达［J］. 北京大学学报：医学版, 2013, 45(4): 537541. |
